Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
Clinical trial NCT00340834 · COMPLETED
Trial details
- NCT number
- NCT00340834
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2011-07-01
- Enrollment
- 1292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.